Quinton Oswald

Quinton Oswald

Director/Board Member at
Notal Vision Ltd.

Net worth: - $ as of 30/06/2026

75 year
Health Technology
Commercial Services
Health Services

Profile

Quinton C.
Oswald
currently works at Notal Vision Ltd., as Director from 2019.
Mr. Oswald also formerly worked at SARcode Bioscience, Inc., as Chief Executive Officer from 2010 to 2013, Neurotech Pharmaceuticals, Inc. (United States), as President & Chief Executive Officer, Opthea Ltd., as Independent Non-Executive Director from 2022 to 2025, Genentech, Inc., as Vice President & Head-Business Unit, QLT, Inc., as Principal, Novartis Corp., as Principal, and Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd., as Principal.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/09/2025 0 ( -.--% ) - $ 30/06/2026

Quinton Oswald active positions

CompaniesPositionStart
Director/Board Member 04/05/2016

Former positions of Quinton Oswald

CompaniesPositionEnd
CERYVYN THERAPEUTICS LIMITED Director/Board Member 02/06/2025
Chief Executive Officer 01/04/2013
Chief Executive Officer -
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Quinton Oswald's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.

  1. Stock Market
  2. Insiders
  3. Quinton Oswald